Financials

  • Market Capitalization 448.58 M
  • Employee 389
  • Founded 1999
  • CEO N/A
  • Website www.standardbio.com
  • Headquarter Delaware, United States
  • FIGI BBG000S8WQB6
  • Industry Diagnostic et Recherche
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-6.4
ratio cours/chiffre d'affaires
5.73

Standard BioTools Inc. - Common Stock

Standard BioTools Inc., previously known as Fluidigm Corp., is an American life science tools company that offers analytical mass cytometry systems for flow cytometry and tissue imaging, along with associated assays and reagents, as well as an automated genomic analysis instrument and a variety of microfluidic arrays, or integrated fluidic circuits, and consumables with fully kitted reagents. Custom assays and services are available with all systems and applications. Standard BioTools sells products to academic research institutions; translational research and medical centers; cancer centers; clinical research laboratories; biopharmaceutical, biotechnology and plant and animal research companies; and contract research organizations.

Nouvelles